SB469 H HHR AM #1

CR 3338


The Committee on Health and Human Resources moves to amend the bill on page two, section two, line eight, after the word “use” by inserting the words “in treatment of opioid use disorder or”.

And,

On page three, section two, line twenty-eight, by striking out the word “pilot”.

And,

On page three, section two, lines thirty-five and thirty-six, by striking out paragraph (E) in its entirety and inserting in lieu thereof a new paragraph (E), to read as follows:

“(E) Provide access to the non-narcotic, long-acting antagonist therapy or FDA-approved, long acting, practitioner-administered medication for the treatment of opioid use disorder included in the program’s medication-assisted treatment; and”.

And,

On page four, section two, lines fifty-seven and fifty-eight, by striking out paragraph (E) in its entirety and inserting in lieu thereof a new paragraph (E), to read as follows:

“(E) Provide access to the non-narcotic, long-acting antagonist therapy or FDA-approved, long acting, practitioner-administered medication for the treatment of opioid use disorder included in the program’s medication-assisted treatment; and”.

And,

On page four, line sixty-four, by striking out the word “pilot”.

And,

On page five, section two, lines seventy-nine and eighty, by striking out paragraph (E) in its entirety and inserting in lieu thereof a new paragraph (E), to read as follows:

“(E) Provide access to the non-narcotic, long-acting antagonist therapy or FDA-approved, long acting, practitioner-administered medication for the treatment of opioid use disorder included in the program’s medication-assisted treatment; and”.

And,

On page five, section two, line eighty-seven, by striking out the word “pilot”.